<p>Guardant Health Inc., a leading precision oncology company, has announced a strategic collaboration with Trial Library, an AI technology company focused on expanding access to oncology clinical trials. The partnership aims to increase equitable access to cancer clinical trials across the United States by integrating Guardant Health’s genomic data with Trial Library’s AI-powered patient matching and navigation platform. This initiative seeks to streamline the identification, referral, and enrollment of diverse and underserved patient populations into precision oncology clinical trials, helping providers offer new treatment opportunities and improving participation rates in cancer research. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251211844578) on December 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

<p>Guardant Health Inc. has partnered with Trial Library to enhance access to cancer clinical trials in the U.S. by integrating genomic data with AI-powered patient matching. This collaboration aims to improve enrollment of diverse patient populations in precision oncology trials, offering new treatment opportunities and boosting participation in cancer research.</p>

Guardant Health Partners with Trial Library to Expand Access to Cancer Clinical Trials